Prospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10232-10241
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10232
Table 3 Risk factors for relapse of patients who underwent curative surgery (n = 57)
VariableUnivariate analysis
Multivariate analysis
Hazard ratio95%CIP valueHazard ratio95%CIP value
Number of high telomerase activity cells
≤ 51.01.0
> 53.5660.988-12.880.0521.9710.471-8.8610.350
fStage
fStage I1.01.0
fStage II3.6350.169-37.960.3373.5760.166-37.350.343
fStage III17.784.065-121.80.0001b13.752.806-100.70.001b
fStage IV239.67.943-77850.005b289.49.331-97330.004b